BioAtla, Inc.
BCAB
$0.356
-$0.0002-0.06%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 11.20% | 34.00% | 44.72% | 68.23% | 41.06% |
Total Depreciation and Amortization | -49.78% | -23.75% | -38.04% | -15.56% | -21.03% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -32.93% | -110.22% | -58.98% | -37.62% | -32.08% |
Change in Net Operating Assets | 431.21% | 91.10% | 46.75% | 38.26% | -111.00% |
Cash from Operations | 26.43% | 47.16% | 43.91% | 81.23% | 20.34% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -80.74% | -- | 6,150.34% | -100.00% | 41.04% |
Repurchase of Common Stock | 73.68% | -123.08% | 100.00% | 74.55% | 67.24% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -116.00% | -2,938.46% | 7,726.05% | 65.85% | 95.65% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 25.37% | 45.91% | 74.94% | 81.23% | 20.95% |